Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9487 |
High Similarity |
NPD4184 |
Clinical (unspecified phase) |
0.908 |
High Similarity |
NPD6595 |
Phase 3 |
0.8834 |
High Similarity |
NPD482 |
Approved |
0.8817 |
High Similarity |
NPD8110 |
Clinical (unspecified phase) |
0.8788 |
High Similarity |
NPD4076 |
Approved |
0.8788 |
High Similarity |
NPD4079 |
Approved |
0.878 |
High Similarity |
NPD749 |
Clinical (unspecified phase) |
0.8757 |
High Similarity |
NPD8431 |
Approved |
0.875 |
High Similarity |
NPD6610 |
Clinical (unspecified phase) |
0.8743 |
High Similarity |
NPD5728 |
Clinical (unspecified phase) |
0.8743 |
High Similarity |
NPD2092 |
Phase 2 |
0.8743 |
High Similarity |
NPD2094 |
Phase 2 |
0.8743 |
High Similarity |
NPD2095 |
Phase 2 |
0.8727 |
High Similarity |
NPD3506 |
Approved |
0.8727 |
High Similarity |
NPD3505 |
Approved |
0.869 |
High Similarity |
NPD2096 |
Phase 2 |
0.869 |
High Similarity |
NPD2091 |
Phase 2 |
0.8675 |
High Similarity |
NPD786 |
Approved |
0.8614 |
High Similarity |
NPD6203 |
Clinical (unspecified phase) |
0.8614 |
High Similarity |
NPD2144 |
Approved |
0.8606 |
High Similarity |
NPD5065 |
Approved |
0.859 |
High Similarity |
NPD3100 |
Discontinued |
0.8571 |
High Similarity |
NPD3038 |
Discontinued |
0.8562 |
High Similarity |
NPD1722 |
Approved |
0.8545 |
High Similarity |
NPD750 |
Phase 2 |
0.8477 |
Intermediate Similarity |
NPD198 |
Clinical (unspecified phase) |
0.8471 |
Intermediate Similarity |
NPD4374 |
Clinical (unspecified phase) |
0.8364 |
Intermediate Similarity |
NPD5069 |
Clinical (unspecified phase) |
0.8313 |
Intermediate Similarity |
NPD1325 |
Approved |
0.8313 |
Intermediate Similarity |
NPD1326 |
Approved |
0.8295 |
Intermediate Similarity |
NPD5575 |
Clinical (unspecified phase) |
0.8274 |
Intermediate Similarity |
NPD4128 |
Approved |
0.8268 |
Intermediate Similarity |
NPD7621 |
Clinical (unspecified phase) |
0.8258 |
Intermediate Similarity |
NPD7948 |
Phase 1 |
0.8253 |
Intermediate Similarity |
NPD4640 |
Approved |
0.8253 |
Intermediate Similarity |
NPD4638 |
Approved |
0.8253 |
Intermediate Similarity |
NPD4639 |
Approved |
0.8225 |
Intermediate Similarity |
NPD6375 |
Clinical (unspecified phase) |
0.8225 |
Intermediate Similarity |
NPD4075 |
Phase 2 |
0.8218 |
Intermediate Similarity |
NPD3961 |
Discontinued |
0.8187 |
Intermediate Similarity |
NPD4462 |
Approved |
0.8187 |
Intermediate Similarity |
NPD4463 |
Approved |
0.8187 |
Intermediate Similarity |
NPD2172 |
Phase 1 |
0.8187 |
Intermediate Similarity |
NPD8072 |
Approved |
0.8187 |
Intermediate Similarity |
NPD8464 |
Clinical (unspecified phase) |
0.8132 |
Intermediate Similarity |
NPD8073 |
Approved |
0.8129 |
Intermediate Similarity |
NPD8386 |
Phase 2 |
0.8098 |
Intermediate Similarity |
NPD7958 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD7957 |
Phase 1 |
0.8072 |
Intermediate Similarity |
NPD3323 |
Discontinued |
0.807 |
Intermediate Similarity |
NPD4181 |
Approved |
0.8063 |
Intermediate Similarity |
NPD4702 |
Approved |
0.8063 |
Intermediate Similarity |
NPD4703 |
Approved |
0.8054 |
Intermediate Similarity |
NPD8493 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD5934 |
Clinical (unspecified phase) |
0.8043 |
Intermediate Similarity |
NPD8272 |
Phase 2 |
0.8036 |
Intermediate Similarity |
NPD2641 |
Approved |
0.8036 |
Intermediate Similarity |
NPD2640 |
Approved |
0.8011 |
Intermediate Similarity |
NPD3486 |
Clinical (unspecified phase) |
0.8011 |
Intermediate Similarity |
NPD7947 |
Clinical (unspecified phase) |
0.7989 |
Intermediate Similarity |
NPD1304 |
Clinical (unspecified phase) |
0.7989 |
Intermediate Similarity |
NPD1038 |
Approved |
0.7975 |
Intermediate Similarity |
NPD2837 |
Discontinued |
0.7952 |
Intermediate Similarity |
NPD1404 |
Approved |
0.7952 |
Intermediate Similarity |
NPD1403 |
Approved |
0.7946 |
Intermediate Similarity |
NPD5901 |
Discontinued |
0.7929 |
Intermediate Similarity |
NPD2185 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD5744 |
Clinical (unspecified phase) |
0.7903 |
Intermediate Similarity |
NPD4862 |
Clinical (unspecified phase) |
0.7884 |
Intermediate Similarity |
NPD8013 |
Clinical (unspecified phase) |
0.7884 |
Intermediate Similarity |
NPD7470 |
Discontinued |
0.787 |
Intermediate Similarity |
NPD2639 |
Approved |
0.787 |
Intermediate Similarity |
NPD2642 |
Approved |
0.7853 |
Intermediate Similarity |
NPD6217 |
Discontinued |
0.7849 |
Intermediate Similarity |
NPD5426 |
Phase 3 |
0.7836 |
Intermediate Similarity |
NPD3609 |
Approved |
0.7836 |
Intermediate Similarity |
NPD3610 |
Approved |
0.7833 |
Intermediate Similarity |
NPD3404 |
Approved |
0.7831 |
Intermediate Similarity |
NPD7825 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD7998 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD484 |
Approved |
0.7799 |
Intermediate Similarity |
NPD3943 |
Clinical (unspecified phase) |
0.7798 |
Intermediate Similarity |
NPD8026 |
Phase 1 |
0.779 |
Intermediate Similarity |
NPD802 |
Phase 2 |
0.776 |
Intermediate Similarity |
NPD8112 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD1592 |
Phase 3 |
0.7749 |
Intermediate Similarity |
NPD7594 |
Clinical (unspecified phase) |
0.7749 |
Intermediate Similarity |
NPD8458 |
Clinical (unspecified phase) |
0.7747 |
Intermediate Similarity |
NPD7619 |
Phase 3 |
0.7747 |
Intermediate Similarity |
NPD7618 |
Phase 3 |
0.7722 |
Intermediate Similarity |
NPD4499 |
Approved |
0.7719 |
Intermediate Similarity |
NPD4779 |
Clinical (unspecified phase) |
0.7708 |
Intermediate Similarity |
NPD8488 |
Clinical (unspecified phase) |
0.7705 |
Intermediate Similarity |
NPD7818 |
Clinical (unspecified phase) |
0.7702 |
Intermediate Similarity |
NPD4637 |
Clinical (unspecified phase) |
0.7702 |
Intermediate Similarity |
NPD3717 |
Discontinued |
0.7701 |
Intermediate Similarity |
NPD5100 |
Phase 3 |
0.7692 |
Intermediate Similarity |
NPD972 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD5254 |
Discontinued |
0.765 |
Intermediate Similarity |
NPD7944 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD5138 |
Approved |
0.7647 |
Intermediate Similarity |
NPD5140 |
Approved |
0.7644 |
Intermediate Similarity |
NPD7809 |
Clinical (unspecified phase) |
0.7641 |
Intermediate Similarity |
NPD8405 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD3607 |
Clinical (unspecified phase) |
0.7624 |
Intermediate Similarity |
NPD5117 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD1661 |
Suspended |
0.7616 |
Intermediate Similarity |
NPD5021 |
Discontinued |
0.7597 |
Intermediate Similarity |
NPD992 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD991 |
Phase 2 |
0.7597 |
Intermediate Similarity |
NPD2118 |
Approved |
0.7597 |
Intermediate Similarity |
NPD2119 |
Approved |
0.759 |
Intermediate Similarity |
NPD8406 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD1853 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD4112 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD5105 |
Approved |
0.7584 |
Intermediate Similarity |
NPD5106 |
Approved |
0.7579 |
Intermediate Similarity |
NPD6838 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD5255 |
Approved |
0.7571 |
Intermediate Similarity |
NPD6277 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD6664 |
Approved |
0.7564 |
Intermediate Similarity |
NPD3476 |
Approved |
0.7564 |
Intermediate Similarity |
NPD3475 |
Approved |
0.7556 |
Intermediate Similarity |
NPD4426 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD706 |
Phase 1 |
0.7545 |
Intermediate Similarity |
NPD2012 |
Clinical (unspecified phase) |
0.7543 |
Intermediate Similarity |
NPD2928 |
Phase 2 |
0.7538 |
Intermediate Similarity |
NPD5612 |
Discontinued |
0.7529 |
Intermediate Similarity |
NPD3116 |
Approved |
0.7529 |
Intermediate Similarity |
NPD3117 |
Approved |
0.7515 |
Intermediate Similarity |
NPD4547 |
Phase 3 |
0.7514 |
Intermediate Similarity |
NPD5590 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD2844 |
Phase 3 |
0.7514 |
Intermediate Similarity |
NPD6141 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3654 |
Approved |
0.75 |
Intermediate Similarity |
NPD2125 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD6180 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD2006 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD2007 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD6476 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD6158 |
Phase 2 |
0.7474 |
Intermediate Similarity |
NPD8093 |
Discontinued |
0.747 |
Intermediate Similarity |
NPD2430 |
Phase 2 |
0.7458 |
Intermediate Similarity |
NPD1272 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD2580 |
Discontinued |
0.7455 |
Intermediate Similarity |
NPD1683 |
Approved |
0.7455 |
Intermediate Similarity |
NPD6148 |
Clinical (unspecified phase) |
0.7449 |
Intermediate Similarity |
NPD6803 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD4601 |
Approved |
0.7447 |
Intermediate Similarity |
NPD4600 |
Approved |
0.7446 |
Intermediate Similarity |
NPD4615 |
Phase 2 |
0.7444 |
Intermediate Similarity |
NPD6178 |
Phase 3 |
0.7439 |
Intermediate Similarity |
NPD3813 |
Approved |
0.7436 |
Intermediate Similarity |
NPD8094 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD6281 |
Approved |
0.7421 |
Intermediate Similarity |
NPD4030 |
Approved |
0.7421 |
Intermediate Similarity |
NPD4028 |
Approved |
0.7421 |
Intermediate Similarity |
NPD3385 |
Approved |
0.7421 |
Intermediate Similarity |
NPD4029 |
Approved |
0.7414 |
Intermediate Similarity |
NPD5862 |
Discovery |
0.7413 |
Intermediate Similarity |
NPD7271 |
Approved |
0.7407 |
Intermediate Similarity |
NPD7903 |
Clinical (unspecified phase) |
0.7401 |
Intermediate Similarity |
NPD2380 |
Approved |
0.7401 |
Intermediate Similarity |
NPD2381 |
Approved |
0.7401 |
Intermediate Similarity |
NPD2382 |
Approved |
0.7396 |
Intermediate Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD1392 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6630 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD2391 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD2385 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD5721 |
Clinical (unspecified phase) |
0.736 |
Intermediate Similarity |
NPD8123 |
Approved |
0.736 |
Intermediate Similarity |
NPD8122 |
Approved |
0.7354 |
Intermediate Similarity |
NPD8248 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD3112 |
Approved |
0.7353 |
Intermediate Similarity |
NPD276 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD3115 |
Approved |
0.7353 |
Intermediate Similarity |
NPD3113 |
Approved |
0.7353 |
Intermediate Similarity |
NPD3114 |
Approved |
0.7346 |
Intermediate Similarity |
NPD2896 |
Discontinued |
0.734 |
Intermediate Similarity |
NPD7731 |
Approved |
0.734 |
Intermediate Similarity |
NPD7730 |
Approved |
0.7333 |
Intermediate Similarity |
NPD3178 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD5066 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD751 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD5067 |
Phase 2 |
0.733 |
Intermediate Similarity |
NPD2121 |
Clinical (unspecified phase) |
0.7323 |
Intermediate Similarity |
NPD5818 |
Discontinued |
0.7318 |
Intermediate Similarity |
NPD8037 |
Clinical (unspecified phase) |
0.7318 |
Intermediate Similarity |
NPD8036 |
Clinical (unspecified phase) |
0.7316 |
Intermediate Similarity |
NPD4511 |
Phase 1 |
0.731 |
Intermediate Similarity |
NPD7970 |
Approved |
0.731 |
Intermediate Similarity |
NPD7971 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD4326 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD2865 |
Clinical (unspecified phase) |
0.7302 |
Intermediate Similarity |
NPD7000 |
Clinical (unspecified phase) |
0.7302 |
Intermediate Similarity |
NPD3825 |
Phase 3 |
0.7302 |
Intermediate Similarity |
NPD6999 |
Discontinued |
0.7302 |
Intermediate Similarity |
NPD3814 |
Phase 1 |
0.7296
|
Intermediate Similarity |
NPD3330 |
Phase 1 |